http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5762246-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-16
filingDate 1980-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6b248fef55bf43572fc2fd685eb69a
publicationDate 1982-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5762246-A
titleOfInvention Cyclic pentapeptide derivative
abstract NEW MATERIAL:The compound of formulaI(R is H, benzyl or tert-butyl; R 1 is lower alkyl; Tyr is L-tryosine; Ile is L-isoleucine; Gln is L-glutamine; Asn is L-asparagine; Asu is L-aminosuberic acid). n EXAMPLE: The compound of formula II. n USE: Synthetic intermediate for an oxytocic. Extremely useful for the preparation of cargtosin for formula III which is a derivative of oxytosin. n PROCESS: The compound of formulaIis prepared by condensing the compound of formula IV (Bu t is tert-butyl; Z is benzyloxycarbonyl) (starting material) successively with desired peptides or amino acids, and cyclizing the product. n COPYRIGHT: (C)1982,JPO&Japio
priorityDate 1980-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6306
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1153
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507320
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410640
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396504
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5351546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454335253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6437065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439302
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399947

Total number of triples: 34.